Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-16
2006-05-16
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800, C514S012200
Reexamination Certificate
active
07045501
ABSTRACT:
New therapeutic uses for BPI protein products that involve treatment of chronic cardiac disease.
REFERENCES:
patent: 5578568 (1996-11-01), Ammons et al.
patent: 5643875 (1997-07-01), Friedmann et al.
patent: 5646114 (1997-07-01), Lambert, Jr.
patent: WO-97/42966 (1997-11-01), None
Fransen et al., Chest 113(5): 1290-1295 (May 1998).
Bouma et al., Chest 111(3): 577583 (Mar. 1997).
Fransen et al., Cardiovascular Research 4: 8530859 (2000).
Bristow, et al. “Dose-Response of Chronic β-Blocker Treatment in Heart Failure from Either Idiopathic Dilated or Ischemic Cardiomyopathy” Circulation, vol. 89, No. 4, pp. 1632-1642 (1994).
Giroir Brett P.
Scannon Patrick J.
Dollard Ann
Rin-Laures Lily
Witz Jean C.
XOMA Technology
LandOfFree
Method of treating chronic cardiac disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating chronic cardiac disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating chronic cardiac disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542127